Narrow your search

Library

KU Leuven (3)

LUCA School of Arts (3)

Odisee (3)

Thomas More Kempen (3)

Thomas More Mechelen (3)

UCLL (3)

UGent (3)

Vlerick Business School (3)

VIVES (3)

VUB (2)

More...

Resource type

book (3)


Language

English (3)


Year
From To Submit

2017 (1)

1999 (1)

1998 (1)

Listing 1 - 3 of 3
Sort by

Book
Lipid-based nanocarriers for drug delivery and diagnosis
Authors: --- ---
ISBN: 0323527302 0323527299 9780323527309 9780323527293 Year: 2017 Publisher: Kidlington, [England] : William Andrew,

Loading...
Export citation

Choose an application

Bookmark

Abstract

Medical applications of liposomes
Authors: ---
ISBN: 9780444829177 0444829172 9780080536088 0080536085 1281019216 9781281019219 9786611019211 Year: 1998 Publisher: Amsterdam ; New York : Elsevier,

Loading...
Export citation

Choose an application

Bookmark

Abstract

The development of liposomes as a drug delivery system has fluctuated since its introduction in the late 1960's by A.D. Bangham. While academic research of liposomes as a model membrane system has always flourished, as the exponential growth of papers can testify, the application of these findings to medically useful products has gone through several crises. Following the original optimism in the 70's and early 80's, a period of severe skepticism ensued at the end of the 80's and beginning of the 90's, culminating in a moderate but real optimism in the mid 90's, as a result of a successful lau

Nonviral vectors for gene therapy
Authors: --- ---
ISBN: 1281050431 9786611050436 0080479774 0123584655 Year: 1999 Publisher: San Diego, CA : Academic Press,

Loading...
Export citation

Choose an application

Bookmark

Abstract

Gene transfer within humans has been an obstacle until about 10 years ago. At that time, it was found that viral vectors were effective carriers of ""healthy genes"" into patients' cells. The problem, however, was that viral vectors proved unnecessarily harmful to humans: subjects experienced inflammatory activity and negative immunological responses to the genes. Viral vectors were also unable to meet the needs of the pharmaceutical community: they were not reproducible in large-scale proportions in cost-effective ways.

Listing 1 - 3 of 3
Sort by